Search
NewGenIvf Group Ltd
NIVFAdd to Watchlist
0.461USD
-0.090-16.42%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
16.53KMarket Cap
0.00P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-16.42%
5 Days
-17.71%
1 Month
-45.21%
6 Months
-94.27%
Year to Date
-94.43%
1 Year
-99.83%
Key Figures
0.459Open
0.499High
896.61KVolume
0.00P/E TTM
0.00P/E Dynamic
--Dividend TTM
2499.03%Turnover Ratio
0.551Prev. Close
0.430Low
172.70KTurnover
LossP/E Static
0.00P/B
0.00%Div Yield TTM
53.60%ROA
1839.00052wk High
0.36Volume Ratio
-524.64KNet Profit
35.88KShares
2576.7328EPS TTM
-0.04Beta
77.23%ROE
0.71652wk Low
12.53%Amplitude
36.79%Gross Margin
16.53KMarket Cap
-2.34Reward/Risk
8.33%Risk Rate
TradingKey Stock Score of NewGenIvf Group Ltd
Currency: USD Updated: 2026-07-02Key Insights
NewGenIvf Group Ltd's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered undervalued, ranking 68 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is relatively high.Over the past month, multiple analysts have rated it as , with the highest price target at 14.12.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
NewGenIvf Group Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
NewGenIvf Group Ltd Highlights
StrengthsRisks
NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
Growing
The company is in a growing phase, with the latest annual income totaling USD 4.73M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 4.73M.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Fairly Valued
The company’s latest PE is 0.00, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 2.51K shares, increasing 45.71% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 2.55.
Analyst Rating
Based on
0
analysts
--
Current Rating
14.120
Target Price
+2461.22%
Upside Space
NewGenIvf Group Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
NewGenIvf Group Ltd Info
NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
Ticker SymbolNIVF
CompanyNewGenIvf Group Ltd
CEOWing Fung (Siu)
Websitehttps://newgenivf.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of NewGenIvf Group Ltd (NIVF)?
The current price of NewGenIvf Group Ltd (NIVF) is 0.46.
What is the symbol of NewGenIvf Group Ltd?
The ticker symbol of NewGenIvf Group Ltd is NIVF.
What is the 52-week high of NewGenIvf Group Ltd?
The 52-week high of NewGenIvf Group Ltd is 1839.00.
What is the 52-week low of NewGenIvf Group Ltd?
The 52-week low of NewGenIvf Group Ltd is 0.72.
What is the market capitalization of NewGenIvf Group Ltd?
The market capitalization of NewGenIvf Group Ltd is 4.73M.
What is the Earnings Per Share (EPS TTM) of NewGenIvf Group Ltd (NIVF)?
The Earnings Per Share (EPS TTM) of NewGenIvf Group Ltd (NIVF) is 2576.73.